Evolution of the Average Target: McKesson Corporation

Evolution of the Average Target - McKesson Corporation

Evolution of the Target Price: McKesson Corporation

Evolution of the Target Price - McKesson Corporation

Changes in Analyst Recommendations: McKesson Corporation

05d4327b74fe64ca438a.c3cnsOAkq4SI7AMvI3-OXUln3XW9j-2NoOW2tG26oNE.GxVQiJFxzbLni3BoYhHMNT0IryHJu6q66pXp_gfu7Z4JRmD42BHAtr2pdA~a892269ed974656bb624334a70b448cc
11-10 Analyst recommendations: Applovin, Cognex, Humana, MetLife, RocketLab… Zonebourse
11-10 JPMorgan Adjusts Price Target on McKesson to $1,255 From $1,042 MT
11-05 Deutsche Bank Adjusts McKesson Price Target to $1,120 From $913 MT
11-05 McKesson Continues 'Impressive' Execution, RBC Says MT
11-05 UBS Adjusts Price Target on McKesson to $1,250 From $1,200, Maintains Buy Rating MT
11-05 RBC Raises Price Target on McKesson to $965 From $845, Keeps Sector Perform Rating MT
11-05 Mizuho Adjusts Price Target on McKesson to $1,050 From $1,020 MT
11-05 Leerink Partners Adjusts Price Target on McKesson to $1,200 From $1,070 MT
11-05 Baird Adjusts Price Target on McKesson to $1,225 From $1,017 MT
11-05 Evercore ISI Adjusts Price Target on McKesson to $1,200 From $1,000 MT
11-05 TD Cowen Adjusts Price Target on McKesson to $1,200 From $1,006 MT
11-05 Nasdaq Tumbles as Wall Street Picks Its Winners and Losers Zonebourse
11-05 Analyst recommendations: Block, Cisco System, Fair Isaac, Skyworks, Duolingo… Zonebourse
10-20 Mizuho Adjusts Price Target on McKesson to $1,020 From $905 MT
10-16 UBS Adjusts McKesson Price Target to $1,200 From $1,080, Maintains Buy Rating MT
10-12 Baird Adjusts Price Target on McKesson to $1,017 From $1,015 MT
10-07 Leerink Partners Adjusts Price Target on McKesson to $1,070 From $1,030 MT
10-07 Truist Downgrades Option Care Health to Buy From Hold on Heels of Announced Sale to McKesson, CD&R; Adjusts PT to $32.05 From $30 MT
09-14 McKesson Continues to Face Medium-Term Headwinds From Declining Employer Coverage of GLP-1, RBC Says MT
09-03 Argus Adjusts Price Target on McKesson to $970 From $850, Maintains Buy Rating MT
08-19 McKesson's Specialty Drug Mix Helps Cushion Pricing Pressure, RBC Says MT
08-19 RBC Initiates McKesson at Sector Perform With $845 Price Target MT
08-18 Barclays Raises Price Target on McKesson to $1,000 From $925, Maintains Overweight Rating MT
08-11 Wells Fargo Adjusts Price Target on McKesson to $933 From $812, Maintains Equalweight Rating MT
08-06 Mizuho Adjusts Price Target on McKesson to $905 From $885 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+6.36%
+3.75%
+0.53%
+7.88%
-2.27%
+12.66%
-3.15%
+18.14%
-5.48%
+3.33%
Average +4.17%
Weighted average by Cap. +3.92%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
1,091.67USD
Average target price
1,161.07USD
Spread / Average Target
+6.36%
High Price Target
1,260.00USD
Spread / Highest target
+15.42%
Low Price Target
965.00USD
Spread / Lowest Target
-11.60%

Analyst Consensus Detail

Analyst consensus - McKesson Corporation

Consensus revision (last 18 months)

Consensus revision (last 18 months) - McKesson Corporation
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
MarketScreener Ratings - McKesson Corporation
  1. Stock Market
  2. Stocks
  3. MCK Stock
  4. Consensus McKesson Corporation